Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/10/20 → 11/30/22 |
Funding
- Avanir Pharmaceuticals: $30,497.00
7-AVP-786-205: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (deudextromethorphan hydrobromide [d6- DM]/quinidine sulfate [Q]) for the Treatment of Neurobehavioral Di
- Lee, Daniel (PI)